Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
Mark Crowther shared a noteworthy post honoring Dr. Davide Matino, faculty member of McMaster University Department of Medicine, on LinkedIn:
“Incredible breakthroughs are happening right here in Hamilton – and McMaster University is at the heart of it.
A promising new hemophilia treatment – described as “life-transforming”- is being tested on local patients, bringing hope to thousands across Canada.
Leading this cutting-edge clinical trial is Dr. Davide Matino, a faculty member in McMaster University Department of Medicine, which boasts decades of global research excellence in hemostasis and thrombosis.
This isn’t just a milestone in medicine-it’s a powerful reminder of the impact academic research can have when paired with compassion and collaboration.
McMaster’s Faculty of Health Sciences continues to lead the way in advancing care and improving lives, both locally and globally.”
Read more about this exciting development here.
Stay uptaded on hematology world news with Hemostasis Today:
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies